Four months after authorizing emergency use of dried plasma by the Department of Defense, FDA released draft guidance that aims to spur industry interest in developing dried plasma products for use beyond the battlefield. The guidance, released Monday (Oct. 29), recommends ways to develop safe and effective dried plasma products for emergency blood transfusions, as well as how to produce devices to manufacture dried plasma products. The guidance includes recommendations such as treating the plasma to ensure it doesn’t carry...